Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial-Reference-Cited by-同舟云学术

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial

Published:2014-10 Issue:9950 Volume:384 Page:1273-1281
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Iijima Kazumoto,Sako Mayumi,Nozu Kandai,Mori Rintaro,Tuchida Nao,Kamei Koichi,Miura Kenichiro,Aya Kunihiko,Nakanishi Koichi,Ohtomo Yoshiyuki,Takahashi Shori,Tanaka Ryojiro,Kaito Hiroshi,Nakamura Hidefumi,Ishikura Kenji,Ito Shuichi,Ohashi Yasuo

Funder

Japan Medical Association Center for Clinical Trials:

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. Nephrotic syndrome in childhood;Eddy;Lancet,2003

2. Predicting the response to cytotoxic therapy for childhood nephrotic syndrome: superiority of response to corticosteroid therapy over histopathologic patterns;Schulman;J Pediatr,1988

3. Non-corticosteroid treatment for nephrotic syndrome in children;Hodson;Cochrane Database Syst Rev,2013

4. Interventions for idiopathic steroid-resistant nephrotic syndrome in children;Hodson;Cochrane Database Syst Rev,2010

5. Effective and safe treatment with cyclosporine in nephrotic children: a prospective, randomized multicenter trial;Ishikura;Kidney Int,2008

Cited by 332 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomised, two-arm (1:1 ratio), double blind, placebo controlled phase III trial to assess the efficacy, safety, cost and cost-effectiveness of Rituximab in treating de novo or relapsing NS in patients with MCD/FSGS (TURING);BMC Nephrology;2024-08-07

2. Anti-nephrin autoantibodies: a paradigm shift in podocytopathies;Nature Reviews Nephrology;2024-07-30

3. Advances in primary glomerulonephritis;British Journal of Hospital Medicine;2024-07-30

4. Minimal Change Disease;Advances in Kidney Disease and Health;2024-07

5. Relapse during and after regular single-dose rituximab treatment in adult patients with steroid-dependent nephrotic syndrome;Clinical and Experimental Nephrology;2024-06-04